Expertise and Experience: Our team stays abreast of the latest advancements in weight management therapies, providing evidence-based treatments
In cancer cells, genetic and epigenetic dysregulation of MYC expression and the loss of checkpoint components unleash the ability of MYC to promote cell growth, eventually leading to malignant transformation 176
This fusion protein resists enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) and slows renal clearance, producing the long half-life that makes once-weekly dosing feasible 2
This delivers therapeutic levels of BPC-157 and TB-500 for tendon repair , joint healing , and tissue regeneration while leveraging GHK-Cu for extracellular matrix support and KPV for inflammation control
Unlike traditional fillers that target fine lines and wrinkles, VOLUMA XC is designed to tackle the deeper structural loss that occurs in the midface, providing a subtle lift and more prominent cheek contours
When used under medical supervision, they can lead to sustainable, clinically significant weight loss
